211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Virginia Commonwealth University
University of California, San Francisco
University of Illinois at Chicago
University of North Carolina, Chapel Hill
University of Chicago
National Institutes of Health Clinical Center (CC)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Office of Rare Diseases (ORD)